Riziero Esposito Abate

RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial

Nicola Normanno, Riziero Esposito Abate, Matilde Lambiase et al. · Annals of Oncology · 2017 · 117 citations

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma

Anna Maria Rachiglio, Riziero Esposito Abate, Alessandra Sacco et al. · Oncotarget · 2016 · 85 citations · Full text

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies

Caterina Ieranò, Dario Righelli, Crescenzo D’Alterio et al. · Journal for ImmunoTherapy of Cancer · 2022 · 60 citations · Full text

Impact of circulating tumor DNA mutant allele fraction on prognosis in <i>RAS</i>‐mutant metastatic colorectal cancer

Élena Elez, Chiara Chianese, Enrique Sanz‐García et al. · Molecular Oncology · 2019 · 52 citations · Full text

Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series

Francesca Falcone, Nicola Normanno, Simona Losito et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2019 · 41 citations

Medicine, Clinical Endpoint, Gynecology +8